Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance (2020)

First Author: JL Orgaz

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.25418/crick.11695458

Publication URI: https://crick.figshare.com/articles/Myosin_II_reactivation_and_cytoskeletal_remodeling_as_a_hallmark_and_a_vulnerability_in_melanoma_therapy_resistance/11695458

Type: Other